These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


200 related items for PubMed ID: 11236030

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Newer treatments for non-Hodgkin's lymphoma: monoclonal antibodies.
    Maloney DG, Press OW.
    Oncology (Williston Park); 1998 Oct; 12(10 Suppl 8):63-76. PubMed ID: 9830635
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antibody therapy for non-Hodgkin's lymphoma.
    Ansell SM.
    Curr Opin Mol Ther; 2004 Apr; 6(2):175-81. PubMed ID: 15195930
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antibody-targeted immunotherapy for treatment of malignancy.
    White CA, Weaver RL, Grillo-López AJ.
    Annu Rev Med; 2001 Apr; 52():125-45. PubMed ID: 11160771
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rituximab (Rituxan/MabThera): the first decade (1993-2003).
    Grillo-López AJ.
    Expert Rev Anticancer Ther; 2003 Dec; 3(6):767-79. PubMed ID: 14686699
    [Abstract] [Full Text] [Related]

  • 16. New agents and future directions in biotherapy.
    Sorokin P.
    Clin J Oncol Nurs; 2002 Dec; 6(1):19-24. PubMed ID: 11842484
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Technology evaluation: CC49 humanized radioimmunoconjugates, National Cancer Institute.
    Sheikh N.
    Curr Opin Mol Ther; 2003 Aug; 5(4):428-32. PubMed ID: 14513687
    [Abstract] [Full Text] [Related]

  • 20. Biokinetics and dosimetry of 188Re-anti-CD20 in patients with non-Hodgkin's lymphoma: preliminary experience.
    Torres-García E, Ferro-Flores G, Arteaga de Murphy C, Correa-González L, Pichardo-Romero PA.
    Arch Med Res; 2008 Jan; 39(1):100-9. PubMed ID: 18068002
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.